Create a Report
Please provide report title
Please provide location
Please provide details
Get alerts and updates for your case! Your contact information is not shown on the website.
This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.
Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Please accept our Terms & Conditions
Add photos or video
We recommend photos and videos to help explain your report
Use camera
Select from library
Email or SMS copy of report
Enter below to get emailed a copy of your report, or sms a link to your report
Please provide email or phone
Please provide email or phone
Please accept our Terms & Conditions
Thank you for your report!
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
Visit our learn pages for more helpful information or, email us: support@safelyhq.com
Goodbye! and best wishes in your recovery
Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

If your report is poison related call 1-800-222-1222 for a free consultation with a live medical poisoning expert

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

Wawa, 1515 N Dupont Hwy, New Castle, DE 19720, United States

Total all time reports:  1
Latest report: April 12, 2020 12:00 PM
Employee tests positive for COVID-19 at Wawa, Wawa, 1515 N Dupont Hwy, New Castle, DE 19720, United States

Employee tests positive for COVID-19 at Wawa

April 12, 2020 12:00 PM

“The Wawa in Wilmington Manor was shut Friday after an employee tested positive for COVID-19.

Source: wdel.com See Less
Reported By SafelyHQ.com User

Related Reports

August 9, 2020 12:00 PM

“A staff members at The Deck at Pere Marquette Park at 1601 Beach St. tested positive for COVID-19 at the end of July.

Source: mlive.com See Less
Reported By SafelyHQ.com User

August 9, 2020 12:00 PM

“An employee at a Dairy Queen in West Duluth, located at 4431 Grand Ave tested positive for COVID-19 on Friday August 7.

Source: duluthnewstribune.com See Less
Reported By SafelyHQ.com User

Employee test positive for Covid-19, Hunter Lake Elementary School, 909 Hunter Lake Dr, Reno, NV 89509, USA

Hunter Lake Elementary School, 909 Hunter Lake Dr, Reno, NV 89509, USA

August 9, 2020 12:00 PM

“A Hunter Lake Elementary School staff member in Reno tested positive for COVID-19 on August 7.

Source: mynews4.com See Less
Reported By SafelyHQ.com User

Five confirmed cases of Covid-19, The Crossing at Union Cross Church, 1650 Pecan Ln, Winston-Salem, NC 27107, USA

The Crossing at Union Cross Church, 1650 Pecan Ln, Winston-Salem, NC 27107, USA

August 9, 2020 12:00 PM

“Three children and two staff members at the Crossing at Union Cross Church's Preschool Afterschool program in Kernersville have tested positive for Covid-19. All cases stem from exposure at the vacation bible school.

Source: wfmynews2.com See Less
Reported By SafelyHQ.com User

Employee test positive for Covid-19, Polson School District Superintendent, 111 4th Ave E, Polson, MT 59860, USA

Polson School District Superintendent, 111 4th Ave E, Polson, MT 59860, USA

August 9, 2020 12:00 PM

“An employee at the Polson School District summer meal program tested positive for COVID-19 on July 28

Source: See Less
Reported By SafelyHQ.com User

August 9, 2020 12:00 PM

“80 workers at O'Briens Fine Food in Co Kildare have tested positive for Covid-19.

Source: irishtimes.com See Less
Reported By SafelyHQ.com User

August 9, 2020 12:00 PM

“A Broward school district employee at the K.C. Wright administrative building in Fort Lauderdale tested positive for the new coronavirus on August 7.

Source: sun-sentinel.com See Less
Reported By SafelyHQ.com User

Employee test positive for Covid-19, Joaquin Superintendent Office, 11109 U.S. 84, Joaquin, TX 75954, USA

Joaquin Superintendent Office, 11109 U.S. 84, Joaquin, TX 75954, USA

August 9, 2020 12:00 PM

“A Joaquin Independent School District employee tested positive for COVID-19 on Friday August 7 and multiple other employees are self-quarantining.

Source: easttexasmatters.com See Less
Reported By SafelyHQ.com User

Employee test positive for Covid-19, The Catholic Diocese of Evansville, 4200 N Kentucky Ave, Evansville, IN 47711, USA

The Catholic Diocese of Evansville, 4200 N Kentucky Ave, Evansville, IN 47711, USA

August 9, 2020 12:00 PM

“A staff member at a Catholic Diocese of Evansville school tested positive for Covid-19 on August 8. The school the employee worked at was not identified.

Source: tristatehomepage.com See Less
Reported By SafelyHQ.com User

Employee test positive for Covid-19, Cuyahoga Heights Schools, 4820 E 71st St, Cleveland, OH 44125, USA

Cuyahoga Heights Schools, 4820 E 71st St, Cleveland, OH 44125, USA

August 9, 2020 12:00 PM

“A trades crew member for the Heights Schools tested positive for COVID-19 last week on July 30.

Source: patch.com See Less
Reported By SafelyHQ.com User

Recent Interesting Reports

July 8, 2020 4:00 PM

“Company name: CME America
Brand name: BodyGuard
Product recalled: Infusion System Administration Set (infusion set)
Reason of the recall: Use of the pump system potentially could cause over-infusion or under-infusion of therapy
FDA Recall date: July 08, 2020
Recall details: PRNewswire/ - CME Am ... See Moreerica, a wholly owned subsidiary of BD (Becton, Dickinson and Company), announced a voluntary recall for all CME America BodyGuard® Infusion System Administration Sets (infusion sets) used with the company's BodyGuard® infusion pumps—that were distributed beginning May 2016 (see complete impacted product list below).  This action was initiated on June 16, 2020. As part of CME America's commitment to quality, following the previously announced recall (April 27, 2020) of the BodyGuard® Infusion Pump Systems, the company conducted additional flow-rate accuracy testing.

This testing revealed that some infusion sets do not meet the ±5% delivery accuracy for the system or the ±13% accuracy identified in the earlier recall notification (bd.com Therefore, the use of the pump system potentially could cause over-infusion or under-infusion of therapy and patient harm. Based on those test results CME America is providing additional information and customer actions regarding its previous recall to include all infusion sets used with the BodyGuard® infusion pump distributed beginning May 2016.

CME America has defined four categories of impacted infusion sets based on delivery inaccuracy variability, two of which (Category A and B) can continue to be used in accordance with the instructions in the recall letter (bd.com CME America also announced on April 27, 2020, the decision to suspend distribution of the BodyGuard® infusion pumps and to remove all existing products from the U.S. market. CME America will work with customers to address the latest expanded infusion set recall and will continue to maintain continuity of care during the COVID-19 pandemic. Until such time that the BodyGuard® pumps have been removed from the market, CMEA will supply accessories and infusion sets in "Category A" and "Category B" to support the infusion pumps, and customers can continue to use the products in accordance with the Operator's Manual and the additional mitigations outlined in the customer letter.

Affected Product Types:

- BodyGuard BodySet
- BodyGuard Microset with Needleless Adaptor
- BodyGuard Microsets
- BodyGuard Microset w/ Non-Vented Spike Connector
- BodyGuard set with Female Luer
- BodyGuard Microset w/ 0.2 mic filter and lower y-site with female luer
- BodyGuard Microsets with Filter
- Standard BodySet with Needleless Connectors
- BodyGuard Microset with Filter and Manual Priming Valve
- CMExpress Microbore Sets
- BodyGuard Microset with Male Luer Connectors
- CMExpress Needleless Y Site Microbore Set

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

July 15, 2020 5:32 AM

“We love a bit of raw chicken and hair in our food! Absolutely disgusting See Less
Reported By SafelyHQ.com User

July 13, 2020 11:27 AM

“Do not order from here See Less
Reported By SafelyHQ.com User

Food product out dated, Burger King, South Vermont Avenue, Los Angeles, CA, USA

Burger King, South Vermont Avenue, Los Angeles, CA, USA

July 17, 2020 2:21 PM

“totally out dated food product. smell like dead meat
whopper See Less
Reported By SafelyHQ.com User

May 26, 2020 9:32 AM

“They're trying to kill me serving me raw chicken See Less
Reported By SafelyHQ.com User

Symptoms, Cranston, RI, USA

Cranston, RI, USA

April 8, 2020 4:39 PM

“Headache, nasal congestion. Have not been around anyone in 3 weeks.....did not leave the house often at all expect the drive thru at Target and Gas. See Less
Reported By SafelyHQ.com User

April 16, 2020 3:00 PM

“Company name: Avet Pharmaceuticals Labs Inc.
Brand name: Heritage
Product recalled: Tetracycline HCl Capsules, 250mg and 500mg
Reason of the recall: Due to low out of specification dissolution results
FDA Recall date: April 16, 2020
Recall details: Avet Pharmaceuticals Inc. (“Avet”), based in ... See MoreEast Brunswick, New Jersey, is initiating a voluntary recall of the following lots of Tetracycline HCl Capsules USP, 250 mg and 500 mg, 100-count bottles listed in the table below to the consumer/user level.

- Tetracycline HCl Capsules 250 mg 100 count. NDC number: 23155-017-01. Lot No: H190666. Expiry Date: JUL 2022
- Tetracycline HCl Capsules 500 mg 100 count. NDC number: 23155-018-01. Lot No: G190609. Expiry Date: JUN 2022
- Tetracycline HCl Capsules 500 mg 100 count. NDC number: 23155-018-01. Lot No: G190610. Expiry Date: JUN 2022
- Tetracycline HCl Capsules 500 mg 100 count. NDC number: 23155-018-01. Lot No: G190611. Expiry Date: JUN 2022
- Tetracycline HCl Capsules 500 mg 100 count. NDC number: 23155-018-01. Lot No: L191027. Expiry Date: NOV 2022
- Tetracycline HCl Capsules 500 mg 100 count. NDC number: 23155-018-01. Lot No: L191028. Expiry Date: NOV 2022
- Tetracycline HCl Capsules 500 mg 100 count. NDC number: 23155-018-01. Lot No: K190953. Expiry Date: OCT 2022
- Tetracycline HCl Capsules 500 mg 100 count. NDC number: 23155-018-01. Lot No: K190952. Expiry Date: OCT 2022

These drug products are manufactured by Avet Pharmaceuticals Labs Inc. and distributed under the Heritage Pharmaceuticals Inc. label. The voluntary recall is being initiated due to low out of specification dissolution test results.

Low dissolution results in less tetracycline available in the body to fight infection. This can lead to treatment failures. For patients with compromised immune systems and the elderly, who may be taking tetracycline to treat a serious infection such as pneumonia, there is a reasonable probability that if there is not enough tetracycline in the body to fight the infection, this could result in rapid progression of the infection and death. To date, Avet has not received adverse event reports or complaints related to this event.

The recalled Tetracycline HCl Capsules 250 mg and 500 mg lots were distributed to wholesalers and distributors Nationwide in United States between August 2019 and March 2020.

Avet is notifying its distributors and customers by a separate notification to distributors and through Qualanex and is arranging for the return of all recalled products. Consumers should contact their doctor for further guidance and potential change of treatment before they stop taking this drug product. Pharmacies and healthcare facilities that have the drug product subject to this recall should immediately stop dispensing this drug product.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

July 21, 2020 11:53 AM

“this is RAW CHICKEN. I opened this up and took a bite without realizing it was raw till I smelt it. 🤮🤢 I am so disappointed ☹️ See Less
Reported By SafelyHQ.com User

June 29, 2020 5:30 PM

“Do your employees know what salmonella is? I waited 20 mins in the drive they lane just to be given raw chicken. Not to mention when I called I was hung up on twice and then asked by management “what ... See Moredo you want me to do about it” umm excuse me? I’d like my money back See Less
Reported By SafelyHQ.com User

June 18, 2020 11:00 PM

“Company name: GSK Consumer Healthcare
Brand name: Robitussin
Product recalled: Cough and cold products
Reason of the recall: Incorrect dosing cups
FDA Recall date: June 18, 2020
Recall details: GSK Consumer Healthcare is voluntarily recalling to the retail level two lots (listed below) of Ch ... See Moreildren's Robitussin® Honey Cough and Chest Congestion DM and one lot of Children's Dimetapp® Cold and Cough, due to the inclusion of incorrect dosing cups. During the review of the packaging documents for these products, GSK discovered that the dosing cups for the Children's Robitussin® Honey product are missing the 5 mL and 10 mL graduations, while the dosing cups for the Children's Dimetapp® product are missing the 10 mL graduation. The dosing cups packaged with both products only have the 20 mL graduation.

There is a potential risk of accidental overdose if caregivers dispensing the syrup do not notice the discrepancies between the graduations printed on the dosing cups and the indicated amounts to be administered (as directed in the instructions for use). Children's Robitussin Honey Cough & Chest Congestion DM contains 10 mg dextromethorphan HBr USP and guaifenesin USP 100 mg per 10 mL, and is labeled for children 4 and older, as well as adults. Children's Dimetapp Cold & Cough contains 2 mg brompheniramine maleate USP, 10 mg dextromethorphan HBr USP, and 5 mg phenylephrine HCl USP per 10 mL, and is labeled for children 6 and older, as well as adults.

Symptoms of overdose of either product may include any of the following: impaired coordination; brain stimulation causing increase in energy, elevation in blood pressure, heart rate, and respiration; a lack of energy and enthusiasm; severe dizziness or drowsiness; slow heart rate; fainting; psychotic behaviour; restlessness; seizure; decreased respiration; nausea; vomiting; constipation; diarrhea; abdominal pain; visual and hearing hallucinations; urinary retention.

As of the date of the recall announcement, GSK Consumer Healthcare has not received any adverse events related to these products or consumer complaints regarding the incorrect dosing cups supplied with the product. The recall is limited to the three lots listed below:

Children's Robitussin® Honey Cough and Chest Congestion DM (4oz)
NDC 0031-8760-12
Lots: 02177 (Exp. Jan. 2022) / 02178 (Exp. Jan. 2022)

Children's Dimetapp® Cold and Cough (8oz)
NDC 0031-2234-19
Lot: CL8292 (Exp. Sep. 2021)

These lots were distributed nationwide between February 5, 2020 and June 3, 2020 within the United States. GSK Consumer Healthcare has notified wholesalers, distributors and retailers to arrange for return of any recalled product. Wholesalers, distributors and retailers with an existing inventory of the lots being recalled should stop distribution and quarantine these lots immediately.

Wholesalers, distributors and retailers that have further distributed the recalled product should notify any accounts or additional locations which may have received the recalled product from them. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration. In December 2018, GlaxoSmithKline plc reached an agreement with Pfizer, Inc. to combine their consumer health businesses into a new Joint Venture. August 01, 2019 was the first day of the new GSK Consumer Healthcare Joint Venture. Thus, when identifying impacted product, please be aware the Pfizer company name will still be present on the label.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User